Amgen Inc. buy Piper Jaffray Companies
Start price
02.01.25
/
50%
€254.50
Target price
02.01.26
€300.51
Performance (%)
10.08%
Price
12.12.25
€270.75
Summary
This prediction is currently active. The BUY prediction by Piper_Jaffray_Compan currently has a performance of 10.08%. A total of €9.41 was paid as dividends for this prediction. This prediction currently runs until 02.01.26. The prediction end date can be changed by Piper_Jaffray_Compan at any time. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -4.430% | -4.430% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $310.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat